Global Night Vision Goggle Market Report 2023-2028: Strong Growth Potential Due to On-Going Conflicts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Night Vision Goggle Market Size, Share, Trends, Forecast, Competitive Analysis, and Growth Opportunity: 2023-2028”... Read more.
EDITED™ Revolutionizes Retail Intelligence With Advanced Product Matching Technology – EDITED Match™
Speed and scale up the process of comparing products and branded assortments to take decisive pricing and product actions with EDITED Match. NEW YORK & LONDON–(BUSINESS... Read more.
Endava Announces Second Quarter Fiscal Year 2024 Results
Q2 FY2024 10.6% Year on Year Revenue Decrease to £183.6 million 8.1% Revenue Decrease at Constant Currency Diluted EPS £0.14 compared to £0.26 in the prior... Read more.
Endava to Acquire GalaxE Solutions to Boost Its Position in North America Healthcare With Delivery from India
LONDON–(BUSINESS WIRE)–Endava (NYSE: DAVA), a leading technology services company combining world-class engineering, industry expertise and a people-centric... Read more.
Global and China Automotive Smart Cockpit Design Trends Report 2023: Display and Interior Designs are Deeply Integrated to Emphasize Emotional Resonance with Users – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Automotive Smart Cockpit Design Trend Report, 2023” report has been added to ResearchAndMarkets.com’s offering.... Read more.
Moody’s Corporation to Present at a Fireside Chat Hosted by Bank of America on March 7, 2024
NEW YORK–(BUSINESS WIRE)–Moody’s Corporation (NYSE: MCO) announced today that Stephen Tulenko, President of Moody’s Analytics, will present at the... Read more.
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage... Read more.
Neurenati Therapeutics Concludes a 1.2 Million $ Seed Financing Round to Develop NEU-001 as a Promising Therapy for Hirschsprung Disease
MONTREAL–(BUSINESS WIRE)–Neurenati Therapeutics is delighted to announce the successful closing of its seed funding round, securing 1.2 million $ from... Read more.
Bristol Myers Squibb Announces New Data from the Long-Term DAYBREAK Study Reinforcing Efficacy and Safety of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis
Sustained efficacy was confirmed with an annualized relapse rate of 0.098 and 67% of patients were relapse-free at six years Safety was consistent with prior findings... Read more.
Montrose Environmental Group Acquires Environmental Consultancy Specializing in Regulatory Services in Rocky Mountain Region
LITTLE ROCK, Ark. & ARVADA, Colo.–(BUSINESS WIRE)–Montrose Environmental Group, Inc. (“Montrose” or “the Company”) (NYSE: MEG), a high-growth... Read more.